Formulary Search

Off-label use. Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.

Only recommended as an option in secondary prevention where other options have been exhausted.

For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.

Specialist to prescribe at least 1 month treatment, prior to transfer of care

Not assessed for formulary status. An application to APC is required.

Specialist team initiation and at least 3 months of treatment prior to any request for primary care prescribing.

A DXA scan is recommended after the first 52 weeks of treatment 

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

On advice from specialist.  

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

Prescribe on advice from specialist e.g. dietitian 

Altraplen Energy is the preferred second line 1.5kcal/ml supplement when required in primary care. Ready to drink supplements should only be prescribed if individual cannot prepare milkshake from powder.

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

Weekly tablets are 35mg. Daily tablets are 5mg.
NOTE - 30mg tablets are licensed for Paget's disease only

30mg tablets are licensed for Paget's disease.

Licensed for up to 6 weeks in Alzheimer's dementia. On initiation, patients need a referal to SABP so that an assessment can be made at 6 weeks to weigh up response to treatment and benefit of treatment v risk of harm.

Licensed for up to 6 weeks in Alzheimer's dementia. On initiation, patients need a referal to SABP so that an assessment can be made at 6 weeks to weigh up response to treatment and benefit of treatment v risk of harm.

Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.

Primary Care prescribing on advice from palliative care specialist team

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.